The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lung cancer immunotherapy outcomes in Hispanic patients.
 
Luis E. Raez
Research Funding - Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Loxo (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst)
 
Teresita Munoz-Antonia
No Relationships to Disclose
 
W. Douglas Cress
No Relationships to Disclose
 
Brian Hunis
Stock and Other Ownership Interests - Gilead Sciences
 
Alberto Chiappori
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech; Merck; Novartis; Pfizer; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; genentech; Novartis
Speakers' Bureau - Boehringer Ingelheim; Celgene; Genentech; Merck; Novartis; Pfizer; Takeda
Research Funding - Bristol-Myers Squibb; Novartis
 
Martin Dietrich
No Relationships to Disclose
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Herman Powery
No Relationships to Disclose
 
Paola Izquierdo
No Relationships to Disclose
 
Daniel Sumarriva
No Relationships to Disclose